BSEVenmax Drugs and Pharmaceuticals Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 21 Apr, 2025 · 12:10 IST

Resignation of Ms. Pratibha Jhawar from the post of Company Secretary & Compliance officer.

Kmp ResignedManagement Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹27.08
prior close
₹26.54
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.5%-3.5% vs market
Pharmaceuticals peers, median of 148sector+0.7%-2.7% vs sector

On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 2.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0+1.5-3.5+0.7-2.7
Next day
-4.0+2.4-6.3+0.9-4.9
2d
-5.9+2.4-8.2+1.6-7.5
3d
-4.0+2.8-6.8+2.8-6.8
4d
-2.1+0.1-2.2-0.7-1.4
5d
+2.7+0.0+2.7-0.9+3.6
1w
+6.0-2.3+8.2-2.6+8.5
15d
-0.4+2.9-3.3-0.2-0.2
1m
+1.1+7.4-6.3+2.7-1.6
2m
-0.5+8.7-9.2+0.6-1.0
3m
+2.0+14.6-12.6+7.8-5.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ms. Pratibha Jhawar has resigned from the post of Company Secretary and Compliance Officer of Venmax Drugs and Pharmaceuticals Ltd, effective April 21, 2025. The resignation, cited as due to personal reasons, was accepted by the Board of Directors at its meeting held on the same day, which ran from 11:00 AM to 11:50 AM. The company has disclosed the details as required under SEBI Listing Regulations. No reason beyond 'personal reasons' has been provided, and no replacement has been announced in this filing.

Likely market impact

The Company Secretary is a Key Managerial Personnel, and her sudden departure may raise short-term governance and compliance concerns for shareholders until a replacement is appointed. The stock price impact is likely minimal unless succession delays trigger further disclosures.